Search
-
The Joan Massagué Lab
… Job Title Assistant Member, Molecular Pharmacology Program, SKI; Medical Oncologist, Department of Medicine Degree MD, PhD Start Year 2014 End Year 2019 Email [email protected] Lab Phone 646-888-2063
-
The Derek Tan Lab
… Job Title Summer Intern Resident, Department of Radiology University of Washington MD, Duke University School of Medicine, 2012 BS, Duke University, 2008 Summer Undergraduate Research Intern, 2007 Degree MD Start Year 2007 Email [email protected]
-
-
-
Our melanoma surgeons are ready to help with compassionate care and the most-advanced sophisticated options available. Read about our approach and how we can help.
… Surgery is often the best option to cure early-stage melanoma (melanoma that hasn’t spread to other areas of the body). It can also be used to treat more advanced disease. At MSK, our patients benefit from the expertise of highly trained surgeons who specialize in the disease. These experts are helping
-
Nuestros cirujanos especialistas en melanoma están listos para ayudar con una atención compasiva y las opciones sofisticadas más avanzadas disponibles. Lea sobre nuestro enfoque y cómo podemos ayudar.
… La cirugía suele ser la mejor opción para curar el melanoma en fase inicial (melanoma que no se ha diseminado a otras zonas del cuerpo). También se puede utilizar para tratar la enfermedad más avanzada. En MSK, nuestros pacientes se benefician de la experiencia de cirujanos altamente capacitados que
-
Learn how our specialists use their extensive experience in caring for people with uterine sarcomas to find the best treatment approach for you.
… Memorial Sloan Kettering specialists have extensive experience in chemotherapy and hormone therapy for uterine sarcomas. We can help identify the best treatment approach for you. Chemotherapy for Uterine Sarcomas Chemotherapy uses drugs to destroy cancer cells or to stop or slow their growth. We may
-
-
News
Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.
… Monday, December 15, 2025 The U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role. These approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types
-
The following lectures at SKI feature topics relevant to the mission of GMTEC and showcase the related expertise of many MSK faculty and external colleagues.
… The following lectures at SKI feature topics relevant to the mission of GMTEC and showcase the related expertise of many MSK faculty and external colleagues. GMTEC’s inaugural symposium took place in 2014, featuring lectures encompassing the major early themes of GMTEC. 2025 January 7th, 2025 Club Mets